Contract award · 5 Dec 2025

Denosumab Services Bromley SEL

NHS South East London Integrated Care Board awarded “Denosumab Services Bromley SEL” to Bromley GP Alliance for £975k. Awarded without open competition.

No competitionHealth & social careLondon

Awarded without open competition

Awarded without open competition. The buyer went directly to one or a few suppliers instead of advertising the contract. Procurement rules allow this only in specific cases, such as extreme urgency, when only one supplier can do the work, or for call-offs from an existing framework.

What “without competition” means

Key facts

Buyer
NHS South East London Integrated Care Board · Body governed by public law
Value
£975,000
Procedure
Award procedure without prior publication of a call for competition
Sector
Health & social care · Health services (CPV 85100000)
Region
London
Timeline
  1. Contract date5 Dec 2025
  2. Published9 Dec 2025Published 4 days after the contract date

Description

Denosumab service's provide patients with their regular specialist denosumab injections, which are typically used as treatment for osteoporosis or for those at high risk of a bone fracture. The purpose of this service is to offer an appropriate alternative for patients in Bromley, who would normally be required to attend the hospital for their 6-monthly injections. This is a GP led service and clinics are run by a senior nurse. This is a notice of the Authorities intention to award under the Most Suitable Provider process This is an existing service and the contract duration is as follows: Contract start - December 2025 Initial term end date - 31st March 2029 Additional optional term end date - 31st March 2031

About the supplier

More from NHS South East London Integrated Care Board

All contracts

More won by Bromley GP Alliance

All contracts

Recent health & social care contracts

Sector overview